Prosecution Insights
Last updated: November 16, 2026
Application No. 18/713,624

ENHANCED FOCAL STIMULATION BY SPATIOTEMPORAL SUMMATION OF NANOSECOND ELECTRIC PULSES

Non-Final OA §103
Filed
May 24, 2024
Priority
Nov 26, 2021 — provisional 63/283,371 +1 more
Examiner
BAKKAR, AYA ZIAD
Art Unit
3792
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Old Dominion University Research Foundation
OA Round
2 (Non-Final)
63%
Grant Probability
Moderate
2-3
OA Rounds
99%
With Interview

Examiner Intelligence

Grants 63% of resolved cases
63%
Career Allowance Rate
125 granted / 199 resolved
-7.2% vs TC avg
Strong +44% interview lift
Without
With
+43.5%
Interview Lift
resolved cases with interview
Typical timeline
Avg Prosecution
34 currently pending
Career history
245
Total Applications
across all art units

Office Action

§103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claim(s) 1-7, 10-12, and 17-31 are rejected under 35 U.S.C. 103 as being unpatentable over US 2020/0147371 Pakhomov et al., hereinafter “Pakhomov” in view of US 8,926,606 Davalos et al., hereinafter “Davalos”. Regarding claim 1, Pakhomov discloses a method of applying energy to a target tissue or cell (Abstract), the method comprising: positioning a targeting electrode on or adjacent to the target tissue or cell (Para 12, 14, 40, and 64; Figure 14A, electrode in region C-C’); applying a first train of sub-microsecond pulses from a first electrode (Para 14-15 and 103; Figure 14A, from electrodes a-a’) and a second train of sub-microsecond pulses from a second electrode (Para 14-15 and 103; Figure 14A, from electrodes b-b’), wherein the first and second trains of sub-microsecond pulses (Para 103, see also Para 40 and Figure 14a) are concurrently applied (Para 14-15) and are out of phase so that the first and second trains of sub-microsecond unipolar pulses sum at the target tissue or cell (Para 101 and 105 and see also Figure 14a; to be out of phase means two waves of the same frequency are exactly inverted relative to each other; that is exactly what Figure 14a shows a-a’ and b-b’ are inverted signals that sum at the target tissue c-c’, see also Para 103). Pakhomov does not disclose unipolar pulses. However, Davalos discloses a method/device of applying electrical pulses to tissue (Abstract) and teaches unipolar pulses (Col. 6, lines 26-48; “the individual electric pulses can be monophasic”, see also lines 49-65 that discloses the use of multiple electrodes and note “In certain preferred embodiments, a train of monophasic pulses is delivered in one direction, followed by a subsequent pulse train of opposite polarity” that shows that the pulses are out of phase). It would have been obvious to one of ordinary skill in the art before the effective filling date of the claimed invention to have disclosed unipolar pulses as taught by Davalos, in the invention of Pakhomov, in order for the integration of the pulses to serve in raising the TMP to the critical permeabilizing threshold (Davalos; Col. 11, lines 62-64). Regarding claim 2, Pakhomov discloses the first and second trains of sub- microsecond pulses are 180 degrees out of phase (Para 101 and 105 and see also Figure 14a; to be 180 degrees out of phase means two waves of the same frequency are exactly inverted relative to each other; that is exactly what Figure 14a shows a-a’ and b-b’ are inverted signals that sum at the target tissue c-c’). Pakhomov does not disclose unipolar pulses. However, Davalos teaches unipolar pulses (Col. 6, lines 26-48; “the individual electric pulses can be monophasic”, see also lines 49-65 that discloses the use of multiple electrodes and note “In certain preferred embodiments, a train of monophasic pulses is delivered in one direction, followed by a subsequent pulse train of opposite polarity” that shows that the pulses are out of phase). It would have been obvious to one of ordinary skill in the art before the effective filling date of the claimed invention to have disclosed unipolar pulses as taught by Davalos, in the invention of Pakhomov, in order for the integration of the pulses to serve in raising the TMP to the critical permeabilizing threshold (Davalos; Col. 11, lines 62-64). Regarding claim 3, Pakhomov discloses the first and second trains are concurrently applied (Para 14-15) so that both the targeting electrode and the first electrode operate as a ground electrode when the second electrode is delivering a pulse of the second train of sub-microsecond pulses, and both the targeting electrode and the second electrode operate as a ground electrode when the first electrode is delivering a pulse of the first train of sub-microsecond unipolar pulses (Para 40). Pakhomov does not disclose unipolar pulses. However, Davalos discloses a method/device of applying electrical pulses to tissue (Abstract) and teaches unipolar pulses (Col. 6, lines 26-48; “the individual electric pulses can be monophasic”, see also lines 49-65 that discloses the use of multiple electrodes and note “In certain preferred embodiments, a train of monophasic pulses is delivered in one direction, followed by a subsequent pulse train of opposite polarity” that shows that the pulses are out of phase). It would have been obvious to one of ordinary skill in the art before the effective filling date of the claimed invention to have disclosed unipolar pulses as taught by Davalos, in the invention of Pakhomov, in order for the integration of the pulses to serve in raising the TMP to the critical permeabilizing threshold (Davalos; Col. 11, lines 62-64). Regarding claim 4, Pakhomov discloses adjusting an amplitude or an electric field strength of the sub-microsecond pulses of the first train of sub-microsecond pulses and of the second train of sub-microsecond pulses to modify an amplitude or an electric field strength of a summed unipolar pulse at the target tissue or cell (Para 23 and 40; also note “to modify an amplitude” is an intended use limitation). Pakhomov does not disclose unipolar pulses. However, Davalos discloses a method/device of applying electrical pulses to tissue (Abstract) and teaches unipolar pulses (Col. 6, lines 26-48; “the individual electric pulses can be monophasic”, see also lines 49-65 that discloses the use of multiple electrodes and note “In certain preferred embodiments, a train of monophasic pulses is delivered in one direction, followed by a subsequent pulse train of opposite polarity” that shows that the pulses are out of phase). It would have been obvious to one of ordinary skill in the art before the effective filling date of the claimed invention to have disclosed unipolar pulses as taught by Davalos, in the invention of Pakhomov, in order for the integration of the pulses to serve in raising the TMP to the critical permeabilizing threshold (Davalos; Col. 11, lines 62-64). Regarding claim 5, Pakhomov discloses the first and the second trains of sub-microsecond pulses have a pulse duration of less than 999 ns (Para 12; this interval is disclosed). Pakhomov does not disclose unipolar pulses. However, Davalos discloses a method/device of applying electrical pulses to tissue (Abstract) and teaches unipolar pulses (Col. 6, lines 26-48; “the individual electric pulses can be monophasic”, see also lines 49-65 that discloses the use of multiple electrodes and note “In certain preferred embodiments, a train of monophasic pulses is delivered in one direction, followed by a subsequent pulse train of opposite polarity” that shows that the pulses are out of phase). It would have been obvious to one of ordinary skill in the art before the effective filling date of the claimed invention to have disclosed unipolar pulses as taught by Davalos, in the invention of Pakhomov, in order for the integration of the pulses to serve in raising the TMP to the critical permeabilizing threshold (Davalos; Col. 11, lines 62-64). Regarding claim 6, Pakhomov discloses applying the first train of sub-microsecond pulses from the first electrode and the second train of sub- microsecond pulses from the second electrode further comprises modifying the target tissue or cell (Para 7, 54, 80, and 104). Pakhomov does not disclose unipolar pulses. However, Davalos discloses a method/device of applying electrical pulses to tissue (Abstract) and teaches unipolar pulses (Col. 6, lines 26-48; “the individual electric pulses can be monophasic”, see also lines 49-65 that discloses the use of multiple electrodes and note “In certain preferred embodiments, a train of monophasic pulses is delivered in one direction, followed by a subsequent pulse train of opposite polarity” that shows that the pulses are out of phase). It would have been obvious to one of ordinary skill in the art before the effective filling date of the claimed invention to have disclosed unipolar pulses as taught by Davalos, in the invention of Pakhomov, in order for the integration of the pulses to serve in raising the TMP to the critical permeabilizing threshold (Davalos; Col. 11, lines 62-64). Regarding claim 7, Pakhomov discloses modifying comprises electroporating, exciting or ablating the target tissue or cell (Para 7, 54, 80, and 104; All are disclosed). Regarding claim 10, Pakhomov discloses the first train of sub-microsecond pulses is applied from both the first electrode (Figure 14a, element a) and a third electrode (Figure 14a, element a’) and the second train of sub-microsecond pulses is applied from both the second electrode (Figure 14a, element b) and a fourth electrode (Figure 14a, element b’). Pakhomov does not disclose unipolar pulses. However, Davalos discloses a method/device of applying electrical pulses to tissue (Abstract) and teaches unipolar pulses (Col. 6, lines 26-48; “the individual electric pulses can be monophasic”, see also lines 49-65 that discloses the use of multiple electrodes and note “In certain preferred embodiments, a train of monophasic pulses is delivered in one direction, followed by a subsequent pulse train of opposite polarity” that shows that the pulses are out of phase). It would have been obvious to one of ordinary skill in the art before the effective filling date of the claimed invention to have disclosed unipolar pulses as taught by Davalos, in the invention of Pakhomov, in order for the integration of the pulses to serve in raising the TMP to the critical permeabilizing threshold (Davalos; Col. 11, lines 62-64). Regarding claim 11, Pakhomov discloses the first and the second trains of sub-microsecond pulses sum at the target tissue or cell to form a unipolar pulse having a pulse width that is equivalent to a burst duration of the first train and the second train (Para 17, 49, 113, and 117). Pakhomov does not disclose unipolar pulses. However, Davalos discloses a method/device of applying electrical pulses to tissue (Abstract) and teaches unipolar pulses (Col. 6, lines 26-48; “the individual electric pulses can be monophasic”, see also lines 49-65 that discloses the use of multiple electrodes and note “In certain preferred embodiments, a train of monophasic pulses is delivered in one direction, followed by a subsequent pulse train of opposite polarity” that shows that the pulses are out of phase). It would have been obvious to one of ordinary skill in the art before the effective filling date of the claimed invention to have disclosed unipolar pulses as taught by Davalos, in the invention of Pakhomov, in order for the integration of the pulses to serve in raising the TMP to the critical permeabilizing threshold (Davalos; Col. 11, lines 62-64). Regarding claim 12, Pakhomov discloses positioning the target electrode comprises positioning such that the target tissue or cell(s) is within a comet- shaped region around the targeting electrode, a tail of which extends towards the first and the second electrodes applying the first and the second trains (Figure 14a shows the described shape from electrodes a and b towards tail c-c’), the method further comprising controlling a depth and/or a direction of an electric field at the targeting electrode (Para 100). Regarding claim 17, Pakhomov discloses a system for applying energy to a target tissue or cell (Abstract and Figure 3), the system comprising: a first output configured to couple to a first one or more electrode(s) (Para 61 and 64; every electrode has an output, i.e. applicator; Para 14-15 and 103; Figure 14A, from electrodes a-a’); a second output configured to couple to a second one or more electrode(s) (Para 61 and 64; every electrode has an output, i.e. applicator; Para 14-15 and 103; Figure 14A, from electrodes b-b’); a third output configured to couple to a targeting electrode (Para 61 and 64; every electrode has an output, i.e. applicator; Para 12, 14, 40, and 64; Figure 14A, electrode in region C-C’); a pulse generator (Figure 3, element 305) configured to generate a first train of sub-microsecond pulses (Para 14-15 and 103; Figure 14A, from electrodes a-a’) and a second train of sub-microsecond pulses (Para 14-15 and 103; Figure 14A, from electrodes b-b’), wherein the first and the second trains of sub-microsecond pulses are 180 degrees out of phase (Para 101 and 105 and see also Figure 14a; to be 180 degrees out of phase means two waves of the same frequency are exactly inverted relative to each other; that is exactly what Figure 14a shows a-a’ and b-b’ are inverted signals that sum at the target tissue c-c’); and a controller (Figure 3, element 303) configured to apply the first train of sub-microsecond pulses to the first output concurrently with the second train of sub-microsecond pulses to the second output (Para 17), and to couple the third output to the targeting electrode (Para 17). Pakhomov does not disclose unipolar pulses. However, Davalos discloses a method/device of applying electrical pulses to tissue (Abstract) and teaches unipolar pulses (Col. 6, lines 26-48; “the individual electric pulses can be monophasic”, see also lines 49-65 that discloses the use of multiple electrodes and note “In certain preferred embodiments, a train of monophasic pulses is delivered in one direction, followed by a subsequent pulse train of opposite polarity” that shows that the pulses are out of phase). It would have been obvious to one of ordinary skill in the art before the effective filling date of the claimed invention to have disclosed unipolar pulses as taught by Davalos, in the invention of Pakhomov, in order for the integration of the pulses to serve in raising the TMP to the critical permeabilizing threshold (Davalos; Col. 11, lines 62-64). Regarding claim 18, Pakhomov discloses the first one or more electrode(s) coupled to the pulse generator through the first output (Figure 3 and Para 64; the applicator(s) includes electrodes that couple to pulse generators), the second one or more electrode(s) coupled to the pulse generator through the second output (Figure 3 and Para 64; the applicator(s) includes electrodes that couple to pulse generators), and the targeting electrode coupled to the pulse generator through the third output (Figure 3 and Para 64; the applicator(s) includes electrodes that couple to pulse generators). Regarding claim 19, Pakhomov discloses the first one or more electrode(s) and the second one or more electrode(s) are part of an applicator (Para 64). Regarding claim 20, Pakhomov discloses at least one of the first one or more electrode(s), the second one or more electrode(s) and the targeting electrode comprises a needle electrode (Para 64). Regarding claim 21, Pakhomov discloses at least one of the first one or more electrode(s), the second one or more electrode(s) and the targeting electrode comprises a non-penetrating electrode (Para 64). Regarding claim 22, Pakhomov discloses the controller is integrated with the pulse generator (See Figure 3, the controller and pulse generators are integrated in 301; see also Para 12). Regarding claim 23, Pakhomov discloses the controller is configured to adjust an amplitude or an electric field strength of the first train of sub-microsecond pulses and the second train of the sub-microsecond pulses (Para 23 and 40). Pakhomov does not disclose unipolar pulses. However, Davalos discloses a method/device of applying electrical pulses to tissue (Abstract) and teaches unipolar pulses (Col. 6, lines 26-48; “the individual electric pulses can be monophasic”, see also lines 49-65 that discloses the use of multiple electrodes and note “In certain preferred embodiments, a train of monophasic pulses is delivered in one direction, followed by a subsequent pulse train of opposite polarity” that shows that the pulses are out of phase). It would have been obvious to one of ordinary skill in the art before the effective filling date of the claimed invention to have disclosed unipolar pulses as taught by Davalos, in the invention of Pakhomov, in order for the integration of the pulses to serve in raising the TMP to the critical permeabilizing threshold (Davalos; Col. 11, lines 62-64). Regarding claim 24, Pakhomov discloses the controller is configured to adjust an electric field strength of the first train of sub-microsecond pulses and the second train of sub-microsecond pulses (Para 17) such that an electric field strength of a summed unipolar pulse at the targeting electrode is between 0.01 kV/cm and 10 kV/cm (Para 17). Pakhomov does not disclose unipolar pulses. However, Davalos discloses a method/device of applying electrical pulses to tissue (Abstract) and teaches unipolar pulses (Col. 6, lines 26-48; “the individual electric pulses can be monophasic”, see also lines 49-65 that discloses the use of multiple electrodes and note “In certain preferred embodiments, a train of monophasic pulses is delivered in one direction, followed by a subsequent pulse train of opposite polarity” that shows that the pulses are out of phase). It would have been obvious to one of ordinary skill in the art before the effective filling date of the claimed invention to have disclosed unipolar pulses as taught by Davalos, in the invention of Pakhomov, in order for the integration of the pulses to serve in raising the TMP to the critical permeabilizing threshold (Davalos; Col. 11, lines 62-64). Regarding claim 25, Pakhomov discloses the controller is configured to adjust a burst duration of the first train of sub-microsecond pulses and the second train or sub-microsecond pulses (Para 49, 113, and 117). Pakhomov does not disclose unipolar pulses. However, Davalos discloses a method/device of applying electrical pulses to tissue (Abstract) and teaches unipolar pulses (Col. 6, lines 26-48; “the individual electric pulses can be monophasic”, see also lines 49-65 that discloses the use of multiple electrodes and note “In certain preferred embodiments, a train of monophasic pulses is delivered in one direction, followed by a subsequent pulse train of opposite polarity” that shows that the pulses are out of phase). It would have been obvious to one of ordinary skill in the art before the effective filling date of the claimed invention to have disclosed unipolar pulses as taught by Davalos, in the invention of Pakhomov, in order for the integration of the pulses to serve in raising the TMP to the critical permeabilizing threshold (Davalos; Col. 11, lines 62-64). Regarding claim 26, Pakhomov discloses the controller is configured to adjust the burst duration of the first train of sub-microsecond pulses and the second train of sub- microsecond pulses so that a pulse width of a summed unipolar pulse at the targeting electrode is between 1 microsecond and 100 milliseconds (Para 49, 113, and 117). Pakhomov does not disclose unipolar pulses. However, Davalos discloses a method/device of applying electrical pulses to tissue (Abstract) and teaches unipolar pulses (Col. 6, lines 26-48; “the individual electric pulses can be monophasic”, see also lines 49-65 that discloses the use of multiple electrodes and note “In certain preferred embodiments, a train of monophasic pulses is delivered in one direction, followed by a subsequent pulse train of opposite polarity” that shows that the pulses are out of phase). It would have been obvious to one of ordinary skill in the art before the effective filling date of the claimed invention to have disclosed unipolar pulses as taught by Davalos, in the invention of Pakhomov, in order for the integration of the pulses to serve in raising the TMP to the critical permeabilizing threshold (Davalos; Col. 11, lines 62-64). Regarding claim 27, Pakhomov discloses the first one or more electrode(s), the second one or more electrode(s) and the targeting electrode are arranged to define a triangle or a pyramid (Figure 14a shows the described shape, i.e. a triangle or pyramid, from electrodes a and b towards tail c-c’). Regarding claim 28, Pakhomov discloses the first one or more electrodes comprises a first electrode(Figure 14a, element a) and a fourth electrode (Figure 14a, element a’), the second one or more electrodes comprises the second electrode (Figure 14a, element b) and the fifth electrode (Figure 14a, element b’), the system further comprising a fourth output coupled to the fourth electrode and a fifth output coupled to the fifth electrode (Para 61 and 64; every electrode has an output, i.e. applicator; Para 14-15 and 103), wherein the controller is configured to apply the first train of sub-microsecond pulses to both the first output and the fourth output and to apply the second train of sub-microsecond pulses to both the second output and the fifth output (Para 17 and 40). Pakhomov does not disclose unipolar pulses. However, Davalos discloses a method/device of applying electrical pulses to tissue (Abstract) and teaches unipolar pulses (Col. 6, lines 26-48; “the individual electric pulses can be monophasic”, see also lines 49-65 that discloses the use of multiple electrodes and note “In certain preferred embodiments, a train of monophasic pulses is delivered in one direction, followed by a subsequent pulse train of opposite polarity” that shows that the pulses are out of phase). It would have been obvious to one of ordinary skill in the art before the effective filling date of the claimed invention to have disclosed unipolar pulses as taught by Davalos, in the invention of Pakhomov, in order for the integration of the pulses to serve in raising the TMP to the critical permeabilizing threshold (Davalos; Col. 11, lines 62-64). Regarding claim 29, Pakhomov discloses the first electrode, the second electrode, the fourth electrode and the fifth electrode are part of an applicator (Para 64). Regarding claim 30, Pakhomov discloses the first electrode, the second electrode, the fourth electrode, and the fifth electrode are arranged in a plane (Figures 7 and 15A and Para 64). Regarding claim 31, Pakhomov discloses the targeting electrode, the first electrode, the second electrode, the fourth electrode and the fifth electrode define a pyramid with the targeting electrode at an apex of the pyramid (Figure 14a shows the described shape, i.e. a pyramid, electrodes a, a’, b, and b’ are surface electrodes, electrode c-c’ is a tissue penetrating electrode that sits deeper in the tissue therefore forming a pyramid with the other 4 electrodes). Response to Arguments Applicants’ arguments, filed 07/16/2026, with respect to the claims have been fully considered and are partially persuasive. The Non-final rejection filed on 04/17/2026 has been withdrawn. Examiner agrees that the prior art Pakhomov does not disclose unipolar pulses. Although examiner still takes the stand that Figure 14A still shows a resulting target summed pulse c-c’ that is unipolar. Pakhomov discloses the application of bipolar pulses through electrodes a-a’ and b-b’ that result in a summation c-c’ that is unipolar. This is done via a spatial summation as disclosed by Para 40 and 96. It is also important to note that Para 109 also discloses “A similar effect, taking advantage of megahertz compression as descried above, and spatial summation, may be applied even without bipolar pulsing. For example, in some variations multiple low-electric field monopolar pulse trains that are below the gigahertz frequency may be emitted that, by themselves, have little, if any biological effect, however, when summed spatially in a target region, may result in a high-frequency (e.g., in the megahertz range), pulse train that is sufficient to result in megahertz compression of nanosecond bursts, triggering a bio-effect in the region seeing the summation.” Therefore, Pakhomov discloses unipolar pulses briefly, however, examiner still brought in reference Davalos to teach this limitation even further. Applicant argues that Pakhomov relies on the “CANCAN” effect. And while that may be true, Davalos is doing the same thing with unipolar pulses. Davalos states “In certain preferred embodiments, a train of monophasic pulses is delivered in one direction, followed by a subsequent pulse train of opposite polarity.” Col. 6, lines 37-40 which achieves the same result as the steps in Pakhomov. Next, applicant argues “Further , Pakhomov does not disclose first and second pulse trains being "concurrently applied and out of phase" as claimed”, to which examiner respectfully disagrees. Applicant states “The "out of phase" language of claim 1 is not limited to 180 out of phase but rather covers any offset and simply means that the waveform shapes or timing do not align in the same position within their cycles.” And that is exactly what Pakhomov discloses in Figure 14A on the right side. To be 180 degrees out of phase means two waves of the same frequency are exactly inverted relative to each other; that is exactly what Figure 14a shows a-a’ and b-b’ are inverted signals that sum at the target tissue c-c’. Claim one is not limited to 180 degrees out of phase but encompasses that phase shift, which is clearly shown in Figure 14A. Lastly, regarding applicants’ argument against reference Davalos ‘606, examiner respectfully disagrees. Davalos is relied on to teach unipolar pulses and pulse summations as discussed in the rejection above. Given that Pakhomov discloses the possibility of applying unipolar pulses as states in Para 109, examiner believes it is obvious to combine the two references to teach further that unipolar pulses can lead to a unipolar summation at a target electrode as shown in Davalos and in Pakhomov (achieved using bipolar with a possibility of using monopolar). Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to AYA ZIAD BAKKAR whose telephone number is (313)446-6659. The examiner can normally be reached on 7:30 am - 5:00 pm M-Th. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Benjamin Klein can be reached (571) 270-5213. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of an application may be obtained from the Patent Application Information Retrieval (PAIR) system. Status information for published applications may be obtained from either Private PAIR or Public PAIR. Status information for unpublished applications is available through Private PAIR only. For more information about the PAIR system, see https://ppair-my.uspto.gov/pair/PrivatePair. Should you have questions on access to the Private PAIR system, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative or access to the automated information system, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /AYA ZIAD BAKKAR/ Examiner, Art Unit 3796 /Benjamin J Klein/ Supervisory Patent Examiner, Art Unit 3792
Read full office action

Prosecution Timeline

May 24, 2024
Application Filed
Apr 17, 2026
Non-Final Rejection mailed — §103
Jul 16, 2026
Response Filed
Sep 22, 2026
Non-Final Rejection mailed — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12778482
SYSTEM FOR PREDICTING ORIGIN POSITION OF VENTRICULAR ARRHYTHMIA, AND ELECTRONIC DEVICE AND STORAGE MEDIUM
2y 9m to grant Granted Nov 03, 2026
Patent 12773169
GLUCOSE ESTIMATION WITHOUT CONTINUOUS GLUCOSE MONITORING
2y 6m to grant Granted Oct 27, 2026
Patent 12758424
PLANNING METHODS AND DEVICES FOR PRECISELY CHANGING A REFRACTIVE INDEX
4y 0m to grant Granted Oct 13, 2026
Patent 12758108
IMPROVED PERSONAL HEALTH DATA COLLECTION
4y 3m to grant Granted Oct 13, 2026
Patent 12746399
METHOD AND IMPLANTABLE SYSTEM FOR CONSTANT CURRENT PACING
2y 6m to grant Granted Sep 29, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

2-3
Expected OA Rounds
63%
Grant Probability
99%
With Interview (+43.5%)
Moderate
PTA Risk
Based on 199 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month